Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to $2.5 million.

  • Beauty Health's Share-based Compensation fell 6816.65% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year decrease of 2603.45%. This contributed to the annual value of $26.7 million for FY2024, which is 1841.73% up from last year.
  • According to the latest figures from Q3 2025, Beauty Health's Share-based Compensation is $2.5 million, which was down 6816.65% from $5.3 million recorded in Q2 2025.
  • Over the past 5 years, Beauty Health's Share-based Compensation peaked at $8.5 million during Q2 2023, and registered a low of $34000.0 during Q1 2021.
  • Over the past 5 years, Beauty Health's median Share-based Compensation value was $5.8 million (recorded in 2024), while the average stood at $5.3 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 2063235.29% in 2022, then plummeted by 7036.36% in 2023.
  • Beauty Health's Share-based Compensation (Quarter) stood at $3.8 million in 2021, then surged by 100.82% to $7.6 million in 2022, then tumbled by 70.36% to $2.3 million in 2023, then soared by 159.08% to $5.8 million in 2024, then tumbled by 58.03% to $2.5 million in 2025.
  • Its Share-based Compensation was $2.5 million in Q3 2025, compared to $5.3 million in Q2 2025 and $3.5 million in Q1 2025.